PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignancies (Q37980900)

From Wikidata
Jump to navigation Jump to search
scientific article published on 03 February 2012
edit
Language Label Description Also known as
English
PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignancies
scientific article published on 03 February 2012

    Statements

    PCI-32765: a novel Bruton's tyrosine kinase inhibitor for the treatment of lymphoid malignancies (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit